Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
1.850
+0.050 (2.78%)
At close: Nov 14, 2025, 4:00 PM EST
1.830
-0.020 (-1.08%)
After-hours: Nov 14, 2025, 4:10 PM EST
Adagene Market Cap
Adagene has a market cap or net worth of $86.25 million as of November 14, 2025. Its market cap has decreased by -38.15% in one year.
Market Cap
86.25M
Enterprise Value
30.27M
1-Year Change
-38.15%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $86.25M, a decrease of -89.28%. That is a compound annual growth rate of -37.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 86.25M | -2.10% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | 804.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |